Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14738958 | 1.00 | MAPT (0.37) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL14739368 | 1.00 | MAPT (0.37) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL18426206 | 1.00 | MAPT (0.37) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL30799718 | 1.00 | MAPT (0.37) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL14739314 | 1.00 | MAPT (0.37) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL14739158 | 1.00 | MAPT (0.37) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL973714 | 1.00 | MAPT (0.37) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL14739930 | 1.00 | MAPT (0.37) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL940170 | 0.96 | MAPT (0.39) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 | |
| SCHEMBL6072706 | 0.94 | LMNA (0.38) | MAPTSMN1; SMN2KDM4EALOX15MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9562183-B2 | Use of compounds with nitrogen-containing functional groups for thermal energy storage | ARKEMA FRANCE (FR) | 2017-02-07 | — | — | US | disclosed |
| US-20130056175-A1 | USE OF COMPOUNDS WITH NITROGEN-CONTAINING FUNCTIONAL GROUPS FOR THERMAL ENERGY STORAGE | ARKEMA FRANCE (FR) | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130056175-A1 | USE OF COMPOUNDS WITH NITROGEN-CONTAINING FUNCTIONAL GROUPS FOR THERMAL ENERGY STORAGE | S100A4, NUCB2, C9 | MAPT 636/4885SMN1; SMN2 1052/4885KDM4E 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.